128 related articles for article (PubMed ID: 25855403)
1. Pancreatic cancer: A matter of timing.
Seton-Rogers S
Nat Rev Cancer; 2015 May; 15(5):256-7. PubMed ID: 25855403
[No Abstract] [Full Text] [Related]
2. Brg1 promotes both tumor-suppressive and oncogenic activities at distinct stages of pancreatic cancer formation.
Roy N; Malik S; Villanueva KE; Urano A; Lu X; Von Figura G; Seeley ES; Dawson DW; Collisson EA; Hebrok M
Genes Dev; 2015 Mar; 29(6):658-71. PubMed ID: 25792600
[TBL] [Abstract][Full Text] [Related]
3. Molecular mechanism of intraductal papillary mucinous neoplasm and intraductal papillary mucinous neoplasm-derived pancreatic ductal adenocarcinoma.
Fukuda A
J Hepatobiliary Pancreat Sci; 2015 Jul; 22(7):519-23. PubMed ID: 25900667
[TBL] [Abstract][Full Text] [Related]
4. Putting GWAS to the functional test: NR5A2 and pancreatic cancer risk.
Murtaugh LC
Gut; 2014 Apr; 63(4):535-6. PubMed ID: 23759730
[No Abstract] [Full Text] [Related]
5. Pancreatic cancer: spotlight on BRG1.
McCarthy N
Nat Rev Cancer; 2014 Apr; 14(4):213. PubMed ID: 24622518
[No Abstract] [Full Text] [Related]
6. Pancreatic cancer development and progression: remodeling the model.
Real FX; Cibrián-Uhalte E; Martinelli P
Gastroenterology; 2008 Sep; 135(3):724-8. PubMed ID: 18692502
[No Abstract] [Full Text] [Related]
7. Targeting cathepsins: a new glimmer of hope for pancreatic cancer therapy?
Michl P
Gut; 2012 Jun; 61(6):790-1. PubMed ID: 22287597
[No Abstract] [Full Text] [Related]
8. NPM1 activates metabolic changes by inhibiting FBP1 while promoting the tumorigenicity of pancreatic cancer cells.
Zhu Y; Shi M; Chen H; Gu J; Zhang J; Shen B; Deng X; Xie J; Zhan X; Peng C
Oncotarget; 2015 Aug; 6(25):21443-51. PubMed ID: 26068981
[TBL] [Abstract][Full Text] [Related]
9. ATDC induces an invasive switch in KRAS-induced pancreatic tumorigenesis.
Wang L; Yang H; Abel EV; Ney GM; Palmbos PL; Bednar F; Zhang Y; Leflein J; Waghray M; Owens S; Wilkinson JE; Prasad J; Ljungman M; Rhim AD; Pasca di Magliano M; Simeone DM
Genes Dev; 2015 Jan; 29(2):171-83. PubMed ID: 25593307
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic cancer: New insights into PDAC growth promotion via a BAG3-mediated paracrine loop.
Ray K
Nat Rev Gastroenterol Hepatol; 2015 Dec; 12(12):669. PubMed ID: 26577348
[No Abstract] [Full Text] [Related]
11. Overexpression of PD2 leads to increased tumorigenicity and metastasis in pancreatic ductal adenocarcinoma.
Vaz AP; Deb S; Rachagani S; Dey P; Muniyan S; Lakshmanan I; Karmakar S; Smith L; Johansson S; Lele S; Ouellette M; Ponnusamy MP; Batra SK
Oncotarget; 2016 Jan; 7(3):3317-31. PubMed ID: 26689992
[TBL] [Abstract][Full Text] [Related]
12. Notch signaling: where pancreatic cancer and differentiation meet?
De La O JP; Murtaugh LC
Gastroenterology; 2009 May; 136(5):1499-502. PubMed ID: 19327730
[No Abstract] [Full Text] [Related]
13. The Dual Role of Senescence in Pancreatic Ductal Adenocarcinoma.
Porciuncula A; Hajdu C; David G
Adv Cancer Res; 2016; 131():1-20. PubMed ID: 27451122
[TBL] [Abstract][Full Text] [Related]
14. Finding and killing the CRABs of pancreatic cancer.
Caldwell ME; Tuveson DA
Gastroenterology; 2009 Sep; 137(3):782-5. PubMed ID: 19643193
[No Abstract] [Full Text] [Related]
15. BRG1-deficient dedifferentiated endometrioid adenocarcinoma of the ovary.
Tan A; Mohan GR; Stewart CJ
Pathology; 2016 Jan; 48(1):82-3. PubMed ID: 27020216
[No Abstract] [Full Text] [Related]
16. Intraductal papillary mucinous neoplasms of the pancreas: a plea for prospective differentiation between main-duct and side-branch tumors.
Castillo CF
Ann Surg Oncol; 2005 Feb; 12(2):98-9. PubMed ID: 15827786
[No Abstract] [Full Text] [Related]
17. BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells.
Wang H; Bierie B; Li AG; Pathania S; Toomire K; Dimitrov SD; Liu B; Gelman R; Giobbie-Hurder A; Feunteun J; Polyak K; Livingston DM
Mol Cell; 2016 Jul; 63(2):277-292. PubMed ID: 27373334
[TBL] [Abstract][Full Text] [Related]
18. Acinar-to-ductal metaplasia accompanies c-myc-induced exocrine pancreatic cancer progression in transgenic rodents.
Grippo PJ; Sandgren EP
Int J Cancer; 2012 Sep; 131(5):1243-8. PubMed ID: 22024988
[TBL] [Abstract][Full Text] [Related]
19. Hypoxia but not normoxia promotes Smoothened transcription through upregulation of RBPJ and Mastermind-like 3 in pancreatic cancer.
Onishi H; Yamasaki A; Kawamoto M; Imaizumi A; Katano M
Cancer Lett; 2016 Feb; 371(2):143-50. PubMed ID: 26655998
[TBL] [Abstract][Full Text] [Related]
20. [Symptoms, clinical findings and laboratory data in the pancreatic ductal adenocarcinoma].
Hatori T; Doi M; Yamamoto M
Nihon Rinsho; 2015 Mar; 73 Suppl 3():106-9. PubMed ID: 25856995
[No Abstract] [Full Text] [Related]
[Next] [New Search]
